Dr. Rajappa Vaidyanathan

Dr. Rajappa Vaidyanathan

Group Director-Chemical, Synthetic and Analytical Development at Bristol-Myers Squibb

Director and Head-Process Research and Development, Bristol-Myers Squibb, India

https://in.linkedin.com/in/rajappa-vaidyanathan-b6a4283
rajappa.vaidyanathan@bms.com

Scott Rychnovsky

srychnov@uci.edu

Professor

(949) 824-8292

1139 Natural Sciences II,3038B Frederick Reines Hall

Website: 

 Group Website

Position: 

 Faculty

Faculty Profile

Research Interests

• Chemical Biology
• Organic and Synthetic

Experience

Group Director-Chemical, Synthetic and Analytical Development

Bristol-Myers Squibb

April 2016 – Present (7 months)

Director-Early Phase Chemical Development

Bristol-Myers Squibb

November 2013 – March 2016 (2 years 5 months)Bangalore, India

Head-Process Research and Development

Bristol-Myers Squibb

April 2012 – October 2013 (1 year 7 months)Bangalore

Associate Research Fellow

Pfizer

November 2000 – April 2012 (11 years 6 months)

Education

University of California, Irvine

Ph.D., Chemistry

1995 – 1998

University of Minnesota-Twin Cities

Chemistry

1993 – 1995

Indian Institute of Technology, Madras

Master of Science (M.Sc.), Chemistry

1991 – 1993

Development of Safe, Robust, Environmentally Responsible Processes for New Chemical Entities
- Dr. V. Rajappa, Director & Head-Process R&D, Bristol-Myers Squibb, India

A PRESENTATION





Scroll with mouse to view 76 pages

13.11.2015: An extension lecture by Dr.Rajappa Vaidyanathan; organized by department of Chemical Engineering & Chemistry.




KIRAN SHAW, OWNER, BIOCON

/////////

Ingrid Mergelsberg. Director Merck & Co., Inc., USA

Ingrid Mergelsberg

Director, Process Chemistry
Merck & Co., Inc.,
USA

Rahway , New Jersey , United States

Merck & Co. , Inc.
2000 Galloping Hill Road
Kenilworth , New Jersey 07033
United States

Ingrid Mergelsberg has completed her PhD in Organic Chemistry from the Albert Ludwig University in Freiburg, Germany and her postdoctoral studies from the Rochester University, NY and Hoffmann LaRoche in Basel, Switzerland.
She has published more than 30 papers and patents and has 27 years of experience in Chemical Development within the Pharmaceutical Industry always looking for opportunities to integrate the principles of green chemistry and engineering into the business of drug discovery and productions.
She currently is a Director of Process Chemistry at Merck.
She has served as a co-chair of the ACS Green Chemistry Institute Pharmaceutical Roundtable for two years and is currently leading the Green Chemistry working group and co-chairing the API (Active Pharmaceutical Ingredient) leadership group at the International Consortium for Innovation and Quality in the Pharmaceutical Industry (IQ Consortium).
LINKS
https://www.linkedin.com/pub/ingrid-mergelsberg/23/217/bb




Rochester University




////////////